AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Saponins derived from Ilex pubescens and method of purifying the same

Summary
It introduces a novel triterpene saponin fraction (named PSF) with anti-inflammatory and analgesic activities. Two hitherto unreported novel triterpene saponins were isolated in substantially pure form from the root of Ilex pubescens. The chemical structures and some properties of the triterpene saponin fraction have been elucidated to possess anti-inflammatory and analgesic activity. These two novel triterpene saponins and the triterpene saponin fraction may be used as pharmaceutical compositions in humans and mammals in need of such treatment.
Technology Benefits
Suitable for oral administration with better efficacy, Pure herbal extracts with minimal side effect
Technology Application
Treat inflammation and pain in a mammalation and pain
Detailed Technology Description
It introduces a novel triterpene saponin fraction (named PSF) with anti-inflammatory and analgesic activities, and a pharmaceutical composition containing this fraction, and provides a method of preparing PSF from a plant material by extraction and purification. The plant material can be, for example, the dried root of Ilex pubescens.
Supplementary Information
Patent Number: US7544668B2
Application Number: US2006560849A
Inventor: Liu, Liang | Wang, Jing Rong | Zhou, Hua | Jiang, Zhi Hong
Priority Date: 17 Nov 2006
Priority Number: US7544668B2
Application Date: 17 Nov 2006
Publication Date: 9 Jun 2009
IPC Current: A61K00317004
US Class: 514033 | 424728 | 424736 | 514025 | 514027 | 514462
Assignee Applicant: Hong Kong Baptist University
Title: Saponins derived from Ilex pubescens and method of purifying the same
Usefulness: Saponins derived from Ilex pubescens and method of purifying the same
Summary: (II) is useful to treat inflammation and pain in a mammal. The anti-inflammatory effect of (II) (pubescenoside C and D) was tested in carrageenan induced paw edema in rats. The results showed that (II) reduced the swelling to 52.02± 13.83(%) in 4 hours.
Novelty: Composition, useful to treat inflammation and pain in mammal, comprises mixture of triterpene saponins comprising e.g. ilexsaponin, pubescenoside, ilexsaponin and chikusctsusaponin
Industry
Biomedical
Sub Category
Medical Composition
Application Date
2006.11.07
Application No.
US 11/560,849
Others
Granted
ID No.
A61/LL/Sapo/US01
Country/Region
Hong Kong

For more information, please click Here
Mobile Device